MedPath

Fresenius Kabi Austria Gmbh

Fresenius Kabi Austria Gmbh logo
🇳🇴Norway
Ownership
Subsidiary
Established
1999-01-01
Employees
10K
Market Cap
-
Website
http://www.fresenius-kabi.at

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

92

NMPA:68
PHILIPPINES:15
SFDA:7
+1 more agencies

Drug Approvals

Alanyl Glutamine Injection

Product Name
力太
Approval Number
国药准字HJ20150559
Approval Date
Sep 29, 2024
NMPA

Alanyl Glutamine Injection

Product Name
力太
Approval Number
国药准字HJ20150560
Approval Date
Sep 29, 2024
NMPA

Alanyl Glutamine Injection

Product Name
力太
Approval Number
国药准字HJ20150558
Approval Date
Sep 29, 2024
NMPA

Alanyl Glutamine Injection

Product Name
力太
Approval Number
国药准字HJ20150561
Approval Date
Sep 29, 2024
NMPA

ω-3 Fish Oil Fat Emulsion Injection

Product Name
尤文
Approval Number
国药准字HJ20140950
Approval Date
Apr 2, 2024
NMPA

ω-3 Fish Oil Fat Emulsion Injection

Product Name
尤文
Approval Number
国药准字HJ20140949
Approval Date
Apr 2, 2024
NMPA

ω-3 Fish Oil Fat Emulsion Injection

Product Name
尤文
Approval Number
国药准字HJ20140951
Approval Date
Apr 2, 2024
NMPA

ω-3 Fish Oil Fat Emulsion Injection

Product Name
尤文
Approval Number
国药准字HJ20140952
Approval Date
Apr 2, 2024
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字HJ20170152
Approval Date
Jun 9, 2023
NMPA

Compound Amino Acid(16AA), Glucose(12.6%) and Electrolyte Injection

Product Name
复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液
Approval Number
国药准字HJ20230064
Approval Date
Jun 7, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.